$20.30 0.2%
PHR Stock Price vs. AI Score
Data gathered: November 27

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Phreesia (PHR)

Analysis generated October 27, 2024. Powered by Chat GPT.

Phreesia is a prominent player in the healthcare technology space, specializing in patient intake software that streamlines the patient check-in process, improves clinical workflow, and ensures patient satisfaction. The company serves various healthcare services, including primary care, specialty care, and hospital systems. With its cloud-based platform, Phreesia enables healthcare providers to capture patient information, verify insurance, and collect payments at the point of care, making it a crucial part of the healthcare management ecosystem.

Read full AI stock Analysis

Stock Alerts - Phreesia (PHR)

company logo Phreesia | November 22
Price is up by 5.1% in the last 24h.
company logo Phreesia | November 18
Price is up by 5.2% in the last 24h.
company logo Phreesia | November 15
Price is down by -12.1% in the last 24h.
company logo Phreesia | November 14
Price is down by -6% in the last 24h.

About Phreesia

Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.


Phreesia
Price $20.30
Target Price Sign up
Volume 118,490
Market Cap $1.18B
Year Range $18.04 - $26.01
Dividend Yield 0%
Analyst Rating 90% buy
Earnings Date December 9 '24
Industry Fintech

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24102M67M35M-18M-16M-0.310
Q2 '24101M69M32M-20M-17M-0.350
Q1 '2495M70M25M-31M-27M-0.210
Q4 '2392M73M19M-32M-30M-0.250
Q3 '2386M73M13M-37M-35M-0.340

Insider Transactions View All

Linetsky David filed to sell 200,207 shares at $20.5.
October 22 '24
Hui Yvonne filed to sell 26,805 shares at $21.3.
October 17 '24
Hui Yvonne filed to sell 27,228 shares at $21.
October 17 '24
VanDuyn Amy Beth filed to sell 118,917 shares at $21.
October 17 '24
Gandhi Balaji filed to sell 97,714 shares at $21.
October 17 '24

Congress Trading View All

Politician Filing Date Type Size
Joshua Gottheimer
Democrat
Nov 11, 23 Buy $1K - $15K
Joshua Gottheimer
Democrat
Oct 15, 23 Sell $1K - $15K

What is the Market Cap of Phreesia?

The Market Cap of Phreesia is $1.18B.

When does Phreesia report earnings?

Phreesia will report its next earnings on December 9 '24.

What is the current stock price of Phreesia?

Currently, the price of one share of Phreesia stock is $20.30.

How can I analyze the PHR stock price chart for investment decisions?

The PHR stock price chart above provides a comprehensive visual representation of Phreesia's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Phreesia shares. Our platform offers an up-to-date PHR stock price chart, along with technical data analysis and alternative data insights.

Does PHR offer dividends to its shareholders?

As of our latest update, Phreesia (PHR) does not offer dividends to its shareholders. Investors interested in Phreesia should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Phreesia?

Some of the similar stocks of Phreesia are Block, H&R Block, Morningstar, Paypal, and LendingTree.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.